RSLS   $4.5  -2.39% Market Closed

ReShape Lifesciences Inc
Total Cash 1.05M
totalCashPerShare 2.078
EBITDA -9.19M
Total Debt 216.00K
quickRatio 0.761
currentRatio 1.902
Total Revenue 8.05M
debtToEquity 7.117
Revenue/Share 27.638
ROA -0.63456
ROE -1.8458999
grossProfits
freeCashflow -5.52M
operatingCashflow -8.67M
earningsGrowth
revenueGrowth -0.128
grossMargins 0.67475
ebitdaMargins -1.14256
operatingMargins -1.04529
profitMargins -1.12105
enterpriseValue 2.21M
forwardPE
floatShares 466.55K
sharesOutstanding 506.68K
sharesShort 14.68K
sharesShortPriorMonth 9.95K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 4.55%
heldPercentInstitutions 2.00%
Short Ratio help_outline 0.03%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 5.99
Price To Book help_outline 0.98
earningsQuarterlyGrowth
netIncomeToCommon -9.02M
trailingEps 23.78%
forwardEps -0.36%
enterpriseToEbitda -0.24
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2024
institutionsCount 13
lastUpdated Nov. 7, 2024, 5:08 a.m.